Skip to main content
ArticleOPEN ACCESS

Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions

Cardiovascular Diabetology
DOI: 10.1186/s12933-020-01004-9
4Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The study regarding load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction is very interesting. But there are a few things we need to pay attention to.

Author supplied keywords

Cite

CITATION STYLE

APA

Liang, B., Zhao, Y. X., & Gu, N. (2020, March 10). Empagliflozin improves cardiac function in heart failure with reduced ejection fraction independent of loading conditions. Cardiovascular Diabetology. BioMed Central Ltd. https://doi.org/10.1186/s12933-020-01004-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free